Ramosetron: all 44 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- The Safety and Efficacy of 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Fecal IncontinenceNot yet recruitingNCT06166615Phase 2/3
- 5-HT3 Receptor Antagonist (Ramosetron) vs Loperamide for the Treatment of Low Anterior Resection Syndrome(RALARS)RecruitingNCT05577845Not applicable
- Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) ProphylaxisCompletedNCT02625181Not applicableResults posted
- Additional Anti-emetic Effect of Ramosetron Prophylaxis After Total Knee ArthroplastyCompletedNCT01102491Phase 4Results posted
- Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/CarboplatinCompletedNCT01012336Phase 2Results posted
- Ramosetron on Late PONV (Postoperative Nausea and Vomiting)CompletedNCT05326360Phase 4
- Ramosetron OD Tablet and Postdischarge Nausea and VomitingStatus unknownNCT04297293Phase 4
- Effect of Ramosetron on Post-discharge Nausea and VomitingStatus unknownNCT03409835Not applicable
- Ramosetron Pre-treatment for PONV and QT ProlongationCompletedNCT03278522Phase 4
- Effect of Ramosetron on Heart Rate-corrected QT Interval During Robot-assisted Laparoscopic Prostatectomy With Steep Trendelenburg PositionCompletedNCT03232125Not applicable
- Therapeutic Efficacy of Ramosetron for Treatment of Established PONV After Laparoscopic SurgeryCompletedNCT03017222Not applicable
- Clinical Trial Assessing 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Anterior Resection SyndromeStatus unknownNCT02869984Early Phase 1
- Effect of Ramosetron on Bowel Motility After Gynecological SurgeryStatus unknownNCT02849483Phase 4
- Effect of Ramosetron in Prevention of Intrathecal Morphine Induced Nausea and VomitingCompletedNCT02830906Phase 3
- Post-operative Nausea Vomiting in Laparoscopic CholecystectomyStatus unknownNCT02803788Phase 4
- The Effects of Gabapentin and Ramosetron on Postoperative Nausea and Vomiting in Laparoscopic Gynecological SurgeryStatus unknownNCT02617121Not applicable
- Ramosetron, Aprepitant, and Dexamethasone Versus Palonosetron, Aprepitant, and DexamethasoneCompletedNCT02532634Phase 4
- Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery; Association With ABCB1 PolymorphismCompletedNCT02480088Phase 4
- Anti Emetic Efficacy of Combination of Ramosetron and Premixture of Naloxone With Patient-controlled AnalgesiaCompletedNCT02416115Not applicable
- The Efficacy and Safety of Ramosetron in Patients Undergoing Off Pump Coronary Artery Bypass SurgeryCompletedNCT02139241Not applicable
- Phamacokinetic and Pharmacodynamic Study of Ramosetron in Chemotherapy Induced Nasea and VomitingCompletedNCT02076529Not applicable
- Long Term Prevention of Nausea and Vomiting in Gynecologic LaparoscopyStatus unknownNCT02011659Phase 3
- A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS)CompletedNCT01870895Phase 3
- Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine SurgeryCompletedNCT01825733Not applicable
- Efficacy Study of Antiemetics to Reduce Postoperative Nausea and VomitingCompletedNCT01806948Phase 2
- Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell TransplantationStatus unknownNCT01788605Phase 2
- A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel SyndromeCompletedNCT01736423Phase 3
- Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of HypotensionStatus unknownNCT01669213Not applicable
- Evaluation of Safety and Efficacy of Nasea(R)/Ramosetron Inj. in Patients Undergoing Facial Bone Fracture OperationsTerminatedNCT01637545Phase 4
- Ramosetron, Aprepitant and Dexamethasone Versus Ondansetron, Aprepitant and DexamethasoneStatus unknownNCT01536691Phase 3
- Effect of Ramosetron on Bowel Motility After Colorectal ResectionStatus unknownNCT01427127Phase 4
- A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet and Conventional Tablet Under With Water IntakeCompletedNCT01394653Phase 1
- A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet (Without Water) and Conventional TabletCompletedNCT01392794Phase 1
- A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female PatientsCompletedNCT01274000Phase 2
- A Study to Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male PatientsCompletedNCT01225237Phase 4
- Prophylactic Effects of Ondansetron, Ramosetron, and Palonosetron on Patient-Controlled Analgesia Related Nausea and Vomiting After Urologic Laparoscopic SurgeryCompletedNCT01169805Not applicable
- Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid CancerStatus unknownNCT01046461Phase 2
- The Effect of Oral and Intravenous Ramosetron During Laparoscopic CholecystectomyStatus unknownNCT01041183Not applicable
- Efficacy of Dexamethasone Added to Ramosetron for Preventing Postoperative Nausea and Vomiting in Highly Susceptible Patients Following Spine SurgeryCompletedNCT01013012Phase 4
- Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and VomitingCompletedNCT00971399Phase 3
- A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel SyndromeCompletedNCT00918411Phase 4
- A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and NauseaCompletedNCT00272285Phase 3
- A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)CompletedNCT00189813Phase 2
- Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)CompletedNCT00189696Phase 3